These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 5923255)
41. Regulation of pulmonary Pseudomonas aeruginosa infection by the transcriptional repressor Gfi1. Grassmé H; Jin J; Wilker B; von Kürthy G; Wick W; Weller M; Möröy T; Gulbins E Cell Microbiol; 2006 Jul; 8(7):1096-105. PubMed ID: 16819963 [TBL] [Abstract][Full Text] [Related]
42. Stimulation of respiratory immunity by oral administration of Lactococcus lactis. Villena J; Medina M; Vintiñi E; Alvarez S Can J Microbiol; 2008 Aug; 54(8):630-8. PubMed ID: 18772925 [TBL] [Abstract][Full Text] [Related]
43. Reduced resistance to experimental viral and bacterial infections of mice treated with polychlorinated biphenyl. Imanishi J; Oku T; Oishi K; Kishida T; Nomura H; Mizutani T Biken J; 1984 Dec; 27(4):195-8. PubMed ID: 6443175 [TBL] [Abstract][Full Text] [Related]
44. [Pulmonary nocardiosis in non-immunocompromised patient]. Martínez-Albaladejo M; González-Pina B; Alguacil-García G; de Paco-Moya M An Med Interna; 1995 Aug; 12(8):413-4. PubMed ID: 8924542 [No Abstract] [Full Text] [Related]
46. Detecting lung infections in breathprints: empty promise or next generation diagnosis of infections. Haick H; Cohen-Kaminsky S Eur Respir J; 2015 Jan; 45(1):21-4. PubMed ID: 25552733 [No Abstract] [Full Text] [Related]
47. Applied immunology, histochemistry and microbiology in lung diseases. Report of a symposium. International Union against Tuberculosis and Lung Diseases (European Region) and the Society of Pulmonology and Tuberculosis, 1989. Z Erkr Atmungsorgane; 1991; 176(2-3):85-173. PubMed ID: 1677509 [No Abstract] [Full Text] [Related]
48. Biochemical analyses of the carcass in lethal staphylococcal infections of mice. LINDELL SS; SMITH IM; ROUTH JI; DELLE M Nature; 1963 Jan; 197():155-7. PubMed ID: 13930773 [No Abstract] [Full Text] [Related]
49. Antibacterial mechanisms of the lower respiratory tract. I. Immunoglobulin synthesis and secretion. Hand WL; Cantey JR J Clin Invest; 1974 Feb; 53(2):354-62. PubMed ID: 11344547 [TBL] [Abstract][Full Text] [Related]
50. Alterations of pulmonary defense mechanisms by protein depletion diet. Jakab GJ; Warr GA; Astry CL Infect Immun; 1981 Nov; 34(2):610-22. PubMed ID: 7309243 [TBL] [Abstract][Full Text] [Related]
51. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice. Freter R; O'Brien PC Infect Immun; 1981 Oct; 34(1):222-33. PubMed ID: 7298184 [TBL] [Abstract][Full Text] [Related]
52. Early bacterial clearance from murine lungs. Species-dependent phagocyte response. Rehm SR; Gross GN; Pierce AK J Clin Invest; 1980 Aug; 66(2):194-9. PubMed ID: 6995480 [TBL] [Abstract][Full Text] [Related]
53. Effect of in vivo administration of gold sodium thiomalate on rat macrophage function. Turkall RM; Warr GA; Tsan MF Agents Actions; 1982 Oct; 12(4):489-98. PubMed ID: 6817620 [TBL] [Abstract][Full Text] [Related]
54. Alterations in macrophage functions by environmental chemicals. Gardner DE Environ Health Perspect; 1984 Apr; 55():343-58. PubMed ID: 6376106 [TBL] [Abstract][Full Text] [Related]
55. Pulmonary inflammatory responses during viral pneumonia and secondary bacterial infection. Warr GA; Jakab GJ Inflammation; 1983 Jun; 7(2):93-104. PubMed ID: 6305835 [TBL] [Abstract][Full Text] [Related]
56. Alteration of the pathogenicity of Pasteurella pneumotropica for the murine lung caused by changes in pulmonary antibacterial activity. Goldstein E; Green GM J Bacteriol; 1967 May; 93(5):1651-6. PubMed ID: 6025449 [TBL] [Abstract][Full Text] [Related]
57. Pulmonary antibacterial mechanisms and the pathogenesis of pulmonary disease. Green GM Yale J Biol Med; 1968; 40(5-6):414-35. PubMed ID: 5677121 [No Abstract] [Full Text] [Related]
58. Antibacterial mechanisms of the urinary bladder. Norden CW; Green GM; Kass EH J Clin Invest; 1968 Dec; 47(12):2689-700. PubMed ID: 4881768 [TBL] [Abstract][Full Text] [Related]
59. Direct method for determining the viability of a freshly generated mixed bacterial aerosol. Green LH; Green GM Appl Microbiol; 1968 Jan; 16(1):78-81. PubMed ID: 4865908 [TBL] [Abstract][Full Text] [Related]
60. Pulmonary alveolar macrophage. Defender against bacterial infection of the lung. Goldstein E; Lippert W; Warshauer D J Clin Invest; 1974 Sep; 54(3):519-28. PubMed ID: 4853956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]